
Testimony Set to Begin in First Xarelto Bellwether Trial
Jurors in New Orleans were recently selected for the first Xarelto trial. Xarelto is a blood-thinner that is marketed by Johnson and Johnson. It is a bellwether trial, which means that the outcome of this case will determine how judges may rule in future cases. Over 18,000 lawsuits involving Xarelto have been filed in the U.S. District Court in the